Kintara Therapeutics Probability of Future Stock Price Finishing Under 123.14
| KTRADelisted Stock | USD 6.30 0.14 2.17% |
Kintara |
Kintara Therapeutics Target Price Odds to finish below 123.14
The tendency of Kintara Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 123.14 after 90 days |
| 6.30 | 90 days | 123.14 | close to 99 |
Based on a normal probability distribution, the odds of Kintara Therapeutics to stay under $ 123.14 after 90 days from now is close to 99 (This Kintara Therapeutics probability density function shows the probability of Kintara Stock to fall within a particular range of prices over 90 days) . Probability of Kintara Therapeutics price to stay between its current price of $ 6.30 and $ 123.14 at the end of the 90-day period is about 74.87 .
Given the investment horizon of 90 days Kintara Therapeutics has a beta of 0.18. This indicates as returns on the market go up, Kintara Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Kintara Therapeutics will be expected to be much smaller as well. Additionally Kintara Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Kintara Therapeutics Price Density |
| Price |
Predictive Modules for Kintara Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kintara Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Kintara Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Kintara Therapeutics is not an exception. The market had few large corrections towards the Kintara Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kintara Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kintara Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.44 | |
β | Beta against Dow Jones | 0.18 | |
σ | Overall volatility | 0.88 | |
Ir | Information ratio | -0.07 |
Kintara Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kintara Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kintara Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Kintara Therapeutics is now traded under the symbol HURA. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Kintara Therapeutics is not yet fully synchronised with the market data | |
| Kintara Therapeutics had very high historical volatility over the last 90 days | |
| Kintara Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (8.32 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kintara Therapeutics currently holds about 11.78 M in cash with (7.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15. |
Kintara Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kintara Stock often depends not only on the future outlook of the current and potential Kintara Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kintara Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.6 M | |
| Cash And Short Term Investments | 4.9 M |
Kintara Therapeutics Technical Analysis
Kintara Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Kintara Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kintara Therapeutics. In general, you should focus on analyzing Kintara Stock price patterns and their correlations with different microeconomic environments and drivers.
Kintara Therapeutics Predictive Forecast Models
Kintara Therapeutics' time-series forecasting models is one of many Kintara Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Kintara Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Kintara Therapeutics
Checking the ongoing alerts about Kintara Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kintara Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Kintara Therapeutics is now traded under the symbol HURA. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Kintara Therapeutics is not yet fully synchronised with the market data | |
| Kintara Therapeutics had very high historical volatility over the last 90 days | |
| Kintara Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (8.32 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kintara Therapeutics currently holds about 11.78 M in cash with (7.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.15. |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Kintara Stock
If you are still planning to invest in Kintara Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kintara Therapeutics' history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |